JP2024536039A5 - - Google Patents

Info

Publication number
JP2024536039A5
JP2024536039A5 JP2024518133A JP2024518133A JP2024536039A5 JP 2024536039 A5 JP2024536039 A5 JP 2024536039A5 JP 2024518133 A JP2024518133 A JP 2024518133A JP 2024518133 A JP2024518133 A JP 2024518133A JP 2024536039 A5 JP2024536039 A5 JP 2024536039A5
Authority
JP
Japan
Prior art keywords
methyl
methoxy
tetrahydro
naphthyridine
alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024518133A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024536039A (ja
Filing date
Publication date
Priority claimed from HUP2100338A external-priority patent/HU231691B1/hu
Application filed filed Critical
Publication of JP2024536039A publication Critical patent/JP2024536039A/ja
Publication of JP2024536039A5 publication Critical patent/JP2024536039A5/ja
Pending legal-status Critical Current

Links

JP2024518133A 2021-09-29 2022-09-28 GABAA α5受容体モジュレーターとしての二環式アミン誘導体 Pending JP2024536039A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
HUP2100338A HU231691B1 (hu) 2021-09-29 2021-09-29 GABAA ALFA5 receptor modulátor hatású biciklusos aminszármazékok
HUP2100338 2021-09-29
PCT/IB2022/059214 WO2023053015A1 (en) 2021-09-29 2022-09-28 BICYCLIC AMINE DERIVATIVES AS GABAA α5 RECEPTOR MODULATORS

Publications (2)

Publication Number Publication Date
JP2024536039A JP2024536039A (ja) 2024-10-04
JP2024536039A5 true JP2024536039A5 (enExample) 2025-10-01

Family

ID=89993434

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024518133A Pending JP2024536039A (ja) 2021-09-29 2022-09-28 GABAA α5受容体モジュレーターとしての二環式アミン誘導体

Country Status (21)

Country Link
US (1) US20250051323A1 (enExample)
EP (1) EP4408842A1 (enExample)
JP (1) JP2024536039A (enExample)
KR (1) KR20240089056A (enExample)
CN (1) CN118284606A (enExample)
AR (1) AR127182A1 (enExample)
AU (1) AU2022357572A1 (enExample)
CA (1) CA3231776A1 (enExample)
CL (1) CL2024000893A1 (enExample)
CO (1) CO2024005424A2 (enExample)
CU (1) CU20240013A7 (enExample)
EC (1) ECSP24032316A (enExample)
GE (2) GEAP202416510A (enExample)
HU (1) HU231691B1 (enExample)
IL (1) IL311640A (enExample)
JO (1) JOP20240057A1 (enExample)
MX (1) MX2024003812A (enExample)
PE (1) PE20240816A1 (enExample)
TW (1) TW202330518A (enExample)
WO (1) WO2023053015A1 (enExample)
ZA (1) ZA202403230B (enExample)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2024251133A1 (zh) * 2023-06-05 2024-12-12 武汉人福创新药物研发中心有限公司 作为α5-GABAA受体调节剂的杂环化合物及其用途

Family Cites Families (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU230518B1 (hu) 2005-12-20 2016-10-28 Richter Gedeon Nyrt. Bradykinin B1 receptor szelektív antagonista hatással rendelkező új fenatridin származékok, eljárás előállításukra, és az ezeket tartalmazó gyógyszerkészítmények
HUP0600810A3 (en) 2006-10-27 2008-09-29 Richter Gedeon Nyrt New sulfonamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them
HUP0600808A3 (en) 2006-10-27 2008-09-29 Richter Gedeon Nyrt New benzamide derivatives as bradykinin antagonists, process for their preparation and pharmaceutical compositions containing them
HUP0600809A3 (en) 2006-10-27 2008-09-29 Richter Gedeon Nyrt New phenylsulfamoyl-benzamide derivatives as bradykinin antagonists, process and intermediates for their preparation and pharmaceutical compositions containing them
US7943619B2 (en) 2007-12-04 2011-05-17 Hoffmann-La Roche Inc. Isoxazolo-pyridazine derivatives
US8742097B2 (en) 2010-11-09 2014-06-03 Hoffmann-La Roche Inc. Triazole compounds I
WO2014001279A1 (en) 2012-06-26 2014-01-03 Aniona Aps A phenyl triazole derivative and its use for modulating the gabaa receptor complex
KR20150033679A (ko) 2012-06-26 2015-04-01 사니오나 에이피에스 페닐 트리아졸 유도체 및 이의 gabaa 수용체 복합체 조절용 용도
WO2014001278A1 (en) 2012-06-26 2014-01-03 Aniona Aps A phenyl triazole derivative and its use for modulating the gabaa receptor complex
HUP1300139A2 (en) 2013-03-06 2014-09-29 Richter Gedeon Nyrt Phenoxypiperidine h3 antagonists
CN112409363B (zh) 2013-12-20 2023-11-14 艾吉因生物股份有限公司 用于治疗认知损害的苯并二氮杂䓬衍生物、组合物和方法
PT3439665T (pt) 2016-03-18 2022-09-27 Uwm Res Foundation Inc Tratamento de sintomas cognitivos e de humor em distúrbios neurodegenerativos e neuropsiquiátricos com gaba contendo agonistas de recetores de gabaa contendo alfa5
UA125524C2 (uk) 2016-12-08 2022-04-13 Ф. Хоффманн-Ля Рош Аг Ефірні похідні ізоксазолу як позитивні алостеричні модулятори рецептора гамк а альфа-5
HU231058B1 (hu) 2017-03-13 2020-04-28 Richter Gedeon Nyrt. Gyógyászatilag hatékony aliciklusos-szubsztituált pirazolo[1,5-a]pirimidin származékok
HU231057B1 (hu) 2017-03-13 2020-04-28 Richter Gedeon Nyrt Gyógyászatilag hatékony aril-szubsztituált pirazolo[1,5-a]pirimidin származékok
TW201938171A (zh) 2017-12-15 2019-10-01 匈牙利商羅特格登公司 作為血管升壓素V1a受體拮抗劑之三環化合物
HU231206B1 (hu) 2017-12-15 2021-10-28 Richter Gedeon Nyrt. Triazolobenzazepinek
AU2019286312B2 (en) 2018-06-13 2023-08-17 F. Hoffmann-La Roche Ag New isoxazolyl ether derivatives as GABA A alpha5 PAM
HU231414B1 (hu) 2018-07-13 2023-08-28 Richter Gedeon Nyrt. Tiadiazin származékok
HU231333B1 (hu) 2018-07-13 2023-01-28 Richter Gedeon Nyrt Spirokromán származékok
HU231478B1 (hu) 2018-07-13 2024-02-28 Richter Gedeon Nyrt. Szubsztituált (aza)indol származékok
BR102019014802A2 (pt) 2018-07-20 2020-02-04 Boehringer Ingelheim Int difluorometil-fenil triazóis
HU231223B1 (hu) * 2018-09-28 2022-01-28 Richter Gedeon Nyrt. GABAA A5 receptor modulátor hatású biciklusos vegyületek
TWI901650B (zh) * 2020-03-26 2025-10-21 匈牙利商羅特格登公司 啶及吡啶并〔3,4-c〕嗒衍生物

Similar Documents

Publication Publication Date Title
US20260098036A1 (en) 2-heteroaryl-3-oxo-2,3-dihydropyridazine-4-carboxamides for the treatment of cancer
TWI747846B (zh) 苯內醯胺化合物
JP7010935B2 (ja) Usp30の阻害剤としての活性を有するシアノ置換ヘテロ環
EP3066094B1 (en) Pyrazole for the treatment autoimmune disorders
JP6325078B2 (ja) ヘテロ環式化合物およびその使用
ES2677996T3 (es) Nuevas indazolcarboxamidas, procedimiento para su preparación, preparaciones farmacéuticas que contienen las mismas, así como su uso para la preparación de medicamentos
KR102759231B1 (ko) 키나제 억제제로서의 아미노피롤로트리아진
ES2902806T3 (es) Composiciones que contienen compuestos de [1,2,4]triazolo[1,5-a]pirimidin-7-ilo sustituidos como inhibidores de PDE2
JP2025120943A (ja) 免疫活性化のためのdgkzeta阻害剤としての置換アミノチアゾール類
JP2021514962A (ja) 医薬化合物
TWI865582B (zh) [1,2,4]三唑并[1,5-c]喹唑啉-5-胺
KR102531689B1 (ko) 6,7―디히드로피라졸로[1,5―α]피라진―4(5H)―온 화합물 및 MGLUR2 수용체의 음성 알로스테릭 조절제로서의 그 용도
JP2020530446A5 (enExample)
EA038972B1 (ru) Диметоксифенилзамещенные соединения индола в качестве ингибиторов tlr7, tlr8 или tlr9
JP2021533093A (ja) モノアシルグリセロールリパーゼ阻害剤としての新規複素環化合物
KR102438965B1 (ko) 치환된 5,6,7,8-테트라히드로[1,2,4]트리아졸로[4,3-a]피리딘-3(2H)-온 및 2,5,6,7-테트라히드로-3H-피롤로[2,1-c][1,2,4]트리아졸-3-온, 및 그의 용도
WO2019025440A1 (en) COMBINATION OF ATR KINASE INHIBITORS AND PD-1 / PD-L1 INHIBITORS
US11660301B2 (en) Combination of ATR kinase inhibitors with PARP inhibitors
JP2020526549A5 (enExample)
CN105541693B (zh) 芳杂环类衍生物及其在药物上的应用
KR102646850B1 (ko) 안드로겐 수용체 분해용 화합물 및 이들의 의약 용도
EP2934536B1 (en) FACTOR IXa INHIBITORS
WO2018153972A1 (en) Combination of atr kinase inhibitors and antiandrogens
JP2009500366A5 (enExample)
JP2023520647A5 (enExample)